Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: HESIO
Active substances:
Estonian, English, Latin
ATC code: C05CA86
Dosage form: film-coated tablet
Strength: 900mg+100mg
Legal status for supply*: Not subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated June 30, 2023)
Package information leaflet (PIL): EST  (last updated June 30, 2023)
Labelling:  (last updated June 30, 2023)
Indication: is indicated in adults for: - Treatment of chronic venous insufficiency of the lower extremities in case of the following functional symptoms: • heavy legs and swelling; • pain; • nocturnal cramps of the lower limbs. - Symptomatic treatment of acute haemorrhoidal crisis.
Safety features: No
Marketing authorization holder: Zentiva k.s. 
Marketing authorization number: 1119423 
Marketing authorization issued on: June 30, 2023 
Marketing authorization expires on: June 30, 2028 
Marketing authorization procedure type: Decentralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1871917  HESIO  film-coated tablet  900mg +100mg 18TK  OTC           
1871928  HESIO  film-coated tablet  900mg +100mg 30TK  OTC      17.05.2024     
1871939  HESIO  film-coated tablet  900mg +100mg 36TK  OTC           
1871940  HESIO  film-coated tablet  900mg +100mg 60TK  OTC           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere